AI SLS Forecast


Bullish Case: A favorable Phase 3 data release in Q4 2024 could drive investor confidence and attract new capital, potentially boosting SLS prices due to positive sentiment regarding FDA approvals.


Bearish Case: Continued cash burn and negative trial results may exacerbate existing investor skepticism, leading to further price declines as the market reacts to mounting financial pressures.


Potential Outcomes:

1. 20% chance of positive Phase 3 data boosting prices significantly.

2. 30% chance of price stability due to inconclusive results.

3. 50% chance of further decline based on cash burn and negative news.


Trading Oracle: Sign Up to access trading oracle trade ideas.


September 08, 2024


SELLAS Life Sciences Forecast

SLS      SELLAS Life Sciences











Correlated Assets

Assets that tend to move strongly with SLS



CPNG Forecast + Options Trading Strategies   CPNG  Coupang (0.72)


SMTC Forecast + Options Trading Strategies   SMTC  Semtech (0.72)


HAS Forecast + Options Trading Strategies   HAS  Hasbro (0.71)


ESTA Forecast + Options Trading Strategies   ESTA  Establishment Labs (0.69)


MLI Forecast + Options Trading Strategies   MLI  Mueller Industries (0.68)



Uncorrelated Assets

Assets with little price relationship to SLS



FAST Forecast + Options Trading Strategies   FAST  Fastenal (0.0)


CSGP Forecast + Options Trading Strategies   CSGP  Costar Group (0.0)


PRAA Forecast + Options Trading Strategies   PRAA  PRA (-0.0)


REM Forecast + Options Trading Strategies   REM  iShares Mortgage Real Est (-0.0)


LZB Forecast + Options Trading Strategies   LZB  La-Z-Boy (0.01)



Anticorrelated Assets

Assets that tend to move strongly against SLS



IONS Forecast + Options Trading Strategies   IONS  Ionis Pharmaceuticals (-0.64)


SOXX Forecast + Options Trading Strategies   SOXX  BTC iShares PHLX Semicond (-0.65)


CNXC Forecast + Options Trading Strategies   CNXC  Concentrix (-0.66)


ACAD Forecast + Options Trading Strategies   ACAD  Acadia Pharmaceuticals (-0.67)


IGV Forecast + Options Trading Strategies   IGV  BlackRock Institutional Trust Company N.A. - iShares Expanded Tech-Software Sector (-0.71)





Become a more profitable investor with AI optimized trading strategies






×

Chat with SLS


 Ask any question about SLS!